Kalida Tablet (Calidino-Genase)

Adult dose

Administer 30-150 I.U. per day orally in 3 divided doses. Adjust the dose appropriately according to the patient's age and symptoms.

This drug should not be used in patients with bleeding, such as immediately after cerebral hemorrhage. This drug also contains lactose, so it should not be administered to patients with genetic issues such as galactose intolerance or Lapp lactase deficiency, or glucose-galactose malabsorption. This medication may occasionally cause hypersensitivity symptoms such as skin rashes or itching, so it should be discontinued immediately if such symptoms occur. Rapid heart rate can also occur infrequently, so caution is necessary. Digestive symptoms such as abdominal discomfort, nausea, vomiting, decreased appetite, upper abdominal pain, diarrhea, or constipation may occasionally be observed. Additionally, symptoms such as warmth, headache, a heavy feeling in the head, drowsiness, or fatigue may also be experienced infrequently. In elderly patients, physical function may be weakened, so the dosage should be reduced or used with special caution when administering this drug.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a sealed container that does not allow air to enter, and it is advisable to keep it at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness.

Appearance

White, round, enteric-coated film tablet

Package unit

For domestic use - 30 tablets/bottle, For domestic use - 300 tablets/bottle